INNOCENTI METELLO ENZO

Banfi, A., Barbieri, L., Fiandra, L., Salvioni, L., Innocenti, M., Prosperi, D. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. Intervento presentato a: Next Gen3ration research - September 18-19, 2025, Genoa, Italy. Dettaglio

Sonechkina, M., Rocca, G., Lapi, F., Celant, A., Marcandalli, E., Galli, M., et al. (2025). Single-cell analysis reveals distinct differentiation trajectories and immunoregulatory roles of DC3 subsets in NSCLC. Intervento presentato a: BtBsDay2025, Milano, Italia. Dettaglio

Rocca, G., Celant, A., Sonechkina, M., Stucchi, G., Galli, M., Cozzi, S., et al. (2025). Multimodal analysis of tissue resident dendritic cells reveals the immunosuppressive role of DCs type 3 in human NSCLC and a mouse lung tumor model. Intervento presentato a: BtBs Day 2025, Milano, Italia. Dettaglio

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES, 17(23), 33648-33663 [10.1021/acsami.5c06626]. Dettaglio

Stucchi, G., Marongiu, L., Rocca, G., Galli, M., Celant, A., Cozzi, S., et al. (2025). Mechanoreceptors initiate innate immunity in response to microbial infections. In Abstract Book (pp.27-27). Dettaglio